C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 4/00 (2006.01) A61K 38/00 (2006.01) C07K 7/00 (2006.01) C07K 17/00 (2006.01)
Patent
CA 2648403
Compositions and methods for diagnosing a viral infection and methods of inhibiting such an infection are described. The methods are based on the identification of T-cell receptor gene sequences from cytotoxic T cell clones that are specific for HIV-I or HCV. Soluble T-cell receptor compositions that bind to HLA class I-restricted of HIV and HCV pathogens were identified and constructed.
L'invention concerne des compositions et des méthodes destinées à diagnostiquer une infection virale ainsi que des méthodes d'inhibition de cette infection. Les méthodes sont basées sur l'identification de séquences de gènes de récepteurs de lymphocytes T provenant de clones de lymphocytes T cytotoxiques spécifiques pour le VIH-1 ou le VHC. On a identifié et fabriqué des compositions à base de récepteurs de lymphocytes T solubles se liant à des agents pathogènes du VIH et du VHC à restriction par les molécules HLA de classe I.
Altfeld Marcus
Lauer Georg
Lichterfeld Mathias
Walker Bruce D.
Yu Xu G.
Mbm Intellectual Property Law Llp
The General Hospital Corporation
LandOfFree
Soluble virus-specific t-cell receptor compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble virus-specific t-cell receptor compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble virus-specific t-cell receptor compositions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1734089